GLP-1s May Weaken Pelvic Floor, Impacting Women's Health

The growing popularity of GLP-1 medications has brought attention to their potential impact on women's health, specifically concerning the pelvic floor. Colloquially termed 'Ozempic vagina,' these drugs are linked to changes such as decreased vaginal lubrication and weakened pelvic floor muscles. Rapid weight loss facilitated by GLP-1s can compromise tissue integrity, similar to effects seen in facial fat loss, impacting overall muscle tone.

Common side effects like constipation can further strain the pelvic floor, increasing risks of incontinence and pelvic organ prolapse. While research is ongoing, experts highlight that these issues can lead to painful sex and other discomforts. Strategies to mitigate these symptoms include improving bowel regularity with aids like a Squatty Potty and practicing diaphragmatic breathing.

Pelvic floor physical therapy and diaphragmatic breathing are recommended over solely relying on Kegel exercises, as the latter may not be suitable for everyone. These approaches aim to restore muscle length and flexibility, crucial for a healthy pelvic floor. Ongoing studies are investigating the connection between weight loss treatments and pelvic floor health.